SKYLIGHT Trademark

Trademark Overview

On Monday, October 29, 2018, a trademark application was filed for SKYLIGHT with the United States Patent and Trademark Office. The USPTO has given the SKYLIGHT trademark a serial number of 88173463. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, May 4, 2023. This trademark is owned by Astellas Pharma Global Development, Inc.. The SKYLIGHT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the fields of pharmaceuticals and clinical trials, specifically in the field of treatment of menopause; and scientific study and research in the field of pharmaceuticals for treatment of menopause
skylight

General Information

Serial Number88173463
Word MarkSKYLIGHT
Filing DateMonday, October 29, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, May 4, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 9, 2021

Trademark Statements

Goods and ServicesProviding medical and scientific research information in the fields of pharmaceuticals and clinical trials, specifically in the field of treatment of menopause; and scientific study and research in the field of pharmaceuticals for treatment of menopause

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 13, 2018
Primary Code042
First Use Anywhere DateWednesday, July 10, 2019
First Use In Commerce DateWednesday, July 10, 2019

Trademark Owner History

Party NameAstellas Pharma Global Development, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorthbrook, IL 60062
Party NameAstellas Pharma Global Development, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorthbrook, IL 60062

Trademark Events

Event DateEvent Description
Thursday, May 4, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, May 4, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, May 4, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, October 20, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 20, 2022NON-FINAL ACTION E-MAILED
Thursday, October 20, 2022SU - NON-FINAL ACTION - WRITTEN
Saturday, October 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 14, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, October 6, 2022USE AMENDMENT FILED
Friday, October 14, 2022SOU EXTENSION 3 GRANTED
Thursday, October 6, 2022SOU EXTENSION 3 FILED
Friday, October 14, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 6, 2022SOU TEAS EXTENSION RECEIVED
Thursday, October 6, 2022TEAS STATEMENT OF USE RECEIVED
Wednesday, March 30, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 30, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 30, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, February 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 10, 2022SOU EXTENSION 2 GRANTED
Thursday, February 10, 2022SOU EXTENSION 2 FILED
Thursday, February 10, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, October 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 4, 2021SOU EXTENSION 1 GRANTED
Monday, October 4, 2021SOU EXTENSION 1 FILED
Monday, October 4, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, April 6, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 9, 2021PUBLISHED FOR OPPOSITION
Wednesday, January 20, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, January 3, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, January 3, 2021EXAMINER'S AMENDMENT ENTERED
Sunday, January 3, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sunday, January 3, 2021EXAMINERS AMENDMENT E-MAILED
Sunday, January 3, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, July 2, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, January 1, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, July 1, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, July 1, 2019LETTER OF SUSPENSION E-MAILED
Monday, July 1, 2019SUSPENSION LETTER WRITTEN
Monday, July 1, 2019PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, July 1, 2019NOTICE OF ALLOWANCE CANCELLED
Tuesday, May 14, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 19, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 19, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 7, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 5, 2019ASSIGNED TO EXAMINER
Tuesday, November 13, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 1, 2018NEW APPLICATION ENTERED

Related Keywords

skylight treatment menopause field pharmaceuticals research scientific medical study specifically trials